Duchenne, Married Life, Adoption, & A (FULL) Life Worth Living...
Our 2017 conference date/location…
Are you eligible?
PicMonkey Collage3
Visit www.lgmd-diagnosis.org
<< >>

RSS News

  • Social Workers: Powerful Members of Your Health Care Team November 3, 2016
    For individuals and families living with neuromuscular diseases, having access to the right support is paramount to living life to the fullest. Groundbreaking research, clinical trials and care from the best physicians are critical. But so is everyday help, and that’s where MDA Care Center social workers come in. Social workers can help individuals address […]
  • Why Multidisciplinary Care Matters October 28, 2016
    Clara was 2 years old when she was diagnosed with congenital muscular dystrophy. Her family was referred to their local Minneapolis MDA Care Center, and when they got there, Clara’s mom, Becky, says it felt “a bit like coming home.” Our MDA Care Center is a huge gift for us as working parents managing a […]
  • FDA Will Review Nusinersen for Treatment of SMA October 28, 2016
    The U.S. Food and Drug Administration (FDA) has accepted Biogen’s New Drug Application for nusinersen (brand name Spinraza) for the treatment of spinal muscular atrophy (SMA) and granted Priority Review. Priority Review status is reserved for drugs that offer significant improvements over existing options or provide a treatment for a disorder for which no approved […]
  • Accessing Deflazacort: What You Need to Know October 26, 2016
    The U.S. Food and Drug Administration (FDA) in August accepted Marathon Pharmaceuticals’ New Drug Application for deflazacort for the treatment of Duchenne muscular dystrophy (DMD) and granted Priority Review. A decision on deflazacort, which previously has received Fast Track status, Orphan Drug designation and Rare Pediatric Disease status from the FDA, is anticipated in February […]
  • MDA and RYR-1 Foundation Team Up in the Fight Against RYR1-Related Myopathies October 20, 2016
    MDA and RYR-1 Foundation have announced a partnership aimed at advancing research and clinical care, raising awareness and improving education of patients, medical professionals and the public about RYR1-related myopathies. The partnership represents a key step in MDA’s commitment to form collaborative relationships with other organizations working on the same diseases MDA covers. “MDA is […]

Back to Top